{
  "docId": "019de517-75a1-7387-968b-d0dc513bf421",
  "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
  "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
  "authorId": "ocuphire-pharma",
  "authorName": "Ocuphire Pharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 42,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/9",
  "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
  "deckJsonHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421.json",
  "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.64,
        "w": 0.36,
        "x": 0.617,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Real-World Chart Review of DR Patients in US\n% of Patients\n22% Proliferative diabetic retinopathy (PDR)\n24% Severe non-proliferative diabetic retinopathy (NPDR)\n27% Moderate non-proliferative diabetic retinopathy (NPDR)\n27% Mild non-proliferative diabetic retinopathy (NPDR)",
      "attrs": {},
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8b5f33a8-edbe-401f-a8dd-817a47e150de",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.44,
        "x": 0.13,
        "y": 0.26
      },
      "kind": "diagram",
      "text": "34 Million Diabetics in US\n10M Diabetic Retinopathy (DR)\nNon-Proliferative DR\nProliferative DR\n8M NPDR Patients\n~$6B+",
      "attrs": {},
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0719fd2e-fa02-4049-82a6-f953de3df0e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.06,
        "x": 0.047,
        "y": 0.93
      },
      "kind": "image",
      "text": "Ocuphire",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0518d8ab-9572-4e00-8264-65626f036678",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.29,
        "w": 0.102,
        "x": 0.039,
        "y": 0.506
      },
      "kind": "list",
      "text": "Types of DR\nTarget Patient Population\nUS Market Opportunity",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c92290c6-8ee8-4952-9d37-9e9b29ddcb87",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.07,
        "x": 0.547,
        "y": 0.607
      },
      "kind": "metric",
      "text": "78% NPDR",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a87efd9e-28ff-499a-945c-4052b2099096",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.75,
        "x": 0.12,
        "y": 0.903
      },
      "kind": "source-note",
      "text": "American Diabetes Association; International Diabetes Federation; Healthline; *Ocuphire internal analysis and assumptions; Spherix Global Insights\nPatient survey adapted from Lions International Foundation and International Diabetes Foundation-Europe; Meltzer 2000\nEstimates are provided by the National Eye Institute, FactSheet, Global Data, and Research and Markets. Estimated values are rounded.\nEstimated prevalence in the U.S.; DME- Diabetic Macular Edema; Age-related Macular Degeneration; Geographic Atrophy; Retinal Vein Occlusion",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9710fb94-f21c-4b4e-96d1-4b78ce302fea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.66,
        "x": 0.047,
        "y": 0.08
      },
      "kind": "title",
      "text": "Majority of the DR Patients are NPDR Severity → Target Population for APX3330",
      "attrs": {},
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ef92939-7a9e-4afb-bb13-7b8d2bcf353e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.53,
        "x": 0.047,
        "y": 0.05
      },
      "kind": "title",
      "text": "U.S Diabetic Retinopathy Market",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30ded085-737c-4ed9-9a9c-08f36b4b25cd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 6,
      "beatId": "102a927b-90d9-4296-a592-fca699191176",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Problem & Complication",
      "beatSlug": "consultants-gambit-problem-complication",
      "evidence": "Slides 6-10 describe the Diabetic Retinopathy market and unmet need",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}